Adamind Ltd
03 April 2006
Adamind Ltd
(Adamind or "the Company")
Notification of Interest
Palo Alto: The Company was notified that on 31 March, Emblaze Ltd has sold its
entire shareholding in Adamind. Emblaze sold 17,735,000 existing ordinary shares
of ILS 0.01 ("Ordinary Shares") in Adamind to institutional investors at 110p
per Ordinary Share through a placing with institutional investors by Bridgewell.
Shailendra Jain, CEO of Adamind, said: "Since Adamind was created in November
2004, Emblaze has been a supportive shareholder and has helped us to achieve the
market leading position we occupy today.The sale of Emblaze's holding in Adamind
means that we now have the flexibility to operate as a wholly independent
company and we believe that Adamind's position will be enhanced as a consequence
of that.
"The Company will continue to build on its foundation to chart a successful
future as it expands its business into new territories and deliver sustained
shareholder value."
Enquiries:
Adamind
Shailendra Jain, CEO +972 9769 9500
Eli Sofer, CFO
Corfin Communications
Harry Chathli, Neil Thapar +44 20 7929 8989
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.